Keeler Thomas Management’s GSK GSK Stock Holding History

Keeler Thomas Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,072	Closed	-$473K	–	74
2020 Q3	$473K	Sell	10,072 -1,005	-9%	-$50.4K	0.3%	56
2020 Q2	$564K	Buy	11,077 +217	+2%	+$11.1K	0.41%	52
2020 Q1	$514K	Sell	10,860 -10,660	-50%	-$569K	0.6%	44
2019 Q4	$1.26M	Hold	21,520	–	–	0.9%	36
2019 Q3	$1.15M	Sell	21,520 -1,040	-5%	-$53.5K	0.88%	36
2019 Q2	$1.13M	Sell	22,560 -160	-0.7%	-$8.03K	0.9%	36
2019 Q1	$1.19M	Hold	22,720	–	–	1%	34
2018 Q4	$1.08M	Sell	22,720 -1,520	-6%	-$74.9K	1.25%	27
2018 Q3	$1.22M	Buy	24,240 +1,040	+4%	+$52.8K	1.01%	26
2018 Q2	$1.17M	Hold	23,200	–	–	1.08%	25
2018 Q1	$1.13M	Buy	23,200 +2,640	+13%	+$123K	1.12%	23
2017 Q4	$911K	Buy	+20,560	New	+$950K	0.84%	32

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Keeler Thomas Management's GSK Position: Q4 2020 in Review

Keeler Thomas Management sold out of GSK (GSK) in Q4 2020, closing a stake of 10,072 shares — an estimated $473K sold.

Keeler Thomas Management first reported a position in GSK in Q4 2017 and held it in 12 quarters. The position peaked at $1.26M in Q4 2019. 819 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Keeler Thomas Management reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Keeler Thomas Management sold 10,072 GSK shares in Q4 2020, an estimated $473K.
Keeler Thomas Management first reported a position in GSK in Q4 2017 and held it in 12 quarters.
Keeler Thomas Management's GSK position peaked at $1.26M in Q4 2019.
819 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Keeler Thomas Management's 13F filing for Q4 2020, filed 26 Jan 2021.